Vinorelbine plus Capecitabine (Vinocap): a retrospective analysis in heavily pretreated HER2 negative metastatic breast cancer patients.

Alfredo TorresJeremy L RamdialLuis E AguirreReshma MahtaniCharles L Vogel

Published in: Breast cancer research and treatment (2019)

Vinorelbine/Capecitabine appears to be an active and well-tolerated regimen in women with MBC. In particular, encouraging was the efficacy of VINOCAP as fourth or greater line of chemotherapy.

Keyphrases

phase ii study
locally advanced
squamous cell carcinoma
rectal cancer
open label
radiation therapy
small cell lung cancer
metastatic breast cancer
placebo controlled
phase iii
metastatic colorectal cancer
randomized controlled trial
double blind
chemotherapy induced